Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization

References

• Puebla Neira DA, Watts A, Seashore J, et al. Outcomes of patients with COPD hospitalized for coronavirus disease 2019. Chronic Obstr Pulm Dis. 2021;8(4):517–527. doi:10.15326/JCOPDF.2021.0245
   PubMed Web of Science ®Google Scholar
• Zhao Q, Meng M, Kumar R, et al. The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis. J Med Virol. 2020;92(10):1915–1921. doi:10.1002/JMV.25889
   PubMed Web of Science ®Google Scholar
• Gerayeli FV, Milne S, Cheung C, et al. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33:100789. doi:10.1016/J.ECLINM.2021.100789
   PubMedGoogle Scholar
• Attaway AA, Zein J, Hatipoğlu US. SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: an analysis of Cleveland clinic’s COVID-19 registry. EClinicalMedicine. 2020;26:100515. doi:10.1016/J.ECLINM.2020.100515
   PubMedGoogle Scholar
• Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369. doi:10.1136/bmj.m1966
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Young D, Coupland C, et al. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020;106(19):1503–1511. doi:10.1136/heartjnl-2020-317393
   PubMed Web of Science ®Google Scholar
• Zheng M, Romero GF, Marron RM, et al. Impact of chronic obstructive pulmonary disease and emphysema on outcomes of hospitalized patients with COVID-19 pneumonia. Chronic Obstr Pulm Dis. 2021;8(2):255–268. doi:10.15326/JCOPDF.2020.0200
   PubMed Web of Science ®Google Scholar
• McNaughton CD, Austin PC, Sivaswamy A, et al. Post-acute health care burden after SARS-CoV-2 infection: a retrospective cohort study. CMAJ. 2022;194(40):E1368–E1376. doi:10.1503/CMAJ.220728
   PubMed Web of Science ®Google Scholar
• Grasso ME, Weller WE, Shaffer TJ, Diette GB, Anderson GF. Capitation, managed care, and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(1):133–138. doi:10.1164/AJRCCM.158.1.9710041
   PubMed Web of Science ®Google Scholar
• Regueiro CR, Hamel MB, Davis RB, Desbiens N, Connors AF, Phillips RS. A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospital costs, and survival*. Am J Med. 1998;105:366–372. doi:10.1016/S0002-9343(98)00290-3
   PubMed Web of Science ®Google Scholar
• Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 1996;154(4 I):959–967. doi:10.1164/AJRCCM.154.4.8887592
   PubMed Web of Science ®Google Scholar
• Cydulka RK, Mcfadden ER, Emerman CL, Sivinski LD, Pisanelli W, Rimm AA. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;156(6):1807–1812. doi:10.1164/AJRCCM.156.6.9611008
   PubMed Web of Science ®Google Scholar
• Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization. Arch Intern Med. 2000;160(17):2653–2658. doi:10.1001/ARCHINTE.160.17.2653
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Dharmarajan K, Qin L, Lin Z, Gershon AS, Krumholz HM. Risk trajectories of readmission and death in the first year after hospitalization for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(8):1009–1017. doi:10.1164/rccm.201709-1852OC
   PubMed Web of Science ®Google Scholar
• Puebla Neira DA, Hsu ES, Kuo YF, Ottenbacher KJ, Sharma G. Readmissions reduction program: mortality and readmissions for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(4):437–446. doi:10.1164/rccm.202002-0310OC
   PubMed Web of Science ®Google Scholar
• Verbrugge LM, Patrick DL. Seven chronic conditions: their impact on US adults’ activity levels and use of medical services. Am J Public Health. 1995;85(2):173–182. doi:10.2105/AJPH.85.2.173
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805
   PubMed Web of Science ®Google Scholar
• Vilkman S, Keistinen T, Tuuponen T, Kivela SL. Survival and cause of death among elderly chronic obstructive pulmonary disease patients after first admission to hospital. Respiration. 1997;64(4):281–284. doi:10.1159/000196687
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129(3):536–544. doi:10.1378/CHEST.129.3.536
   PubMed Web of Science ®Google Scholar
• Au DH, Udris EM, Fihn SD, McDonell MB, Curtis JR. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer. Arch Intern Med. 2006;166(3):326–331. doi:10.1001/ARCHINTE.166.3.326
   PubMedGoogle Scholar
• Puebla Neira D, Zaidan MF, Duarte AG, et al. Health Care Utilization of Patients with Chronic Obstructive Pulmonary Disease Post-Discharge from Coronavirus Disease 2019 Hospitalization. American Thoracic Society; 2023.
   Google Scholar
• Hartnett J, Donga P, Ispas G, et al. Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the hospitalized acute respiratory tract infection study. Influenza Other Respi Viruses. 2022;16(5):906–915. doi:10.1111/IRV.12994
   PubMed Web of Science ®Google Scholar
• Lin PJ, Shaya FT, Scharf SM. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med. 2010;104(5):697–704. doi:10.1016/j.rmed.2009.11.009
   PubMed Web of Science ®Google Scholar
• Gerdtham UG, Andersson LF, Ericsson Å, et al. Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort. Eur J Heal Econ. 2009;10(2):217–226. doi:10.1007/S10198-008-0121-6/TABLES/5
   PubMed Web of Science ®Google Scholar
• Simon-Tuval T, Scharf SM, Maimon N, Bernhard-Scharf BJ, Reuveni H, Tarasiuk A. Determinants of elevated healthcare utilization in patients with COPD. Respir Res. 2011;12(1):1–8. doi:10.1186/1465-9921-12-7/TABLES/7
   PubMedGoogle Scholar
• NIHR N. Themed review: living with Covid19 – second review; 2021.
   Google Scholar
• McAlister FA, Dong Y, Chu A, et al. The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario. CMAJ. 2022;194(19):E666–E673. doi:10.1503/CMAJ.220272
   PubMed Web of Science ®Google Scholar
• Tartof SY, Malden DE, Liu I-LA, et al. Health care utilization in the 6 months following SARS-CoV-2 infection. JAMA Netw Open. 2022;5(8):e2225657–e2225657. doi:10.1001/JAMANETWORKOPEN.2022.25657
   PubMed Web of Science ®Google Scholar
• Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021:373. doi:10.1136/BMJ.N1098
   Google Scholar
• Haitao T, Vermunt JV, Abeykoon J, et al. COVID-19 and sex differences: mechanisms and biomarkers. Mayo Clin Proc. 2020;95(10):2189–2203. doi:10.1016/j.mayocp.2020.07.024
   PubMed Web of Science ®Google Scholar
• Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):1–13. doi:10.1186/s13293-020-00301-y
   PubMed Web of Science ®Google Scholar
• Connor J, Madhavan S, Mokashi M, et al. Health risks and outcomes that disproportionately affect women during the Covid-19 pandemic: a review. Soc Sci Med. 2020;266:113364. doi:10.1016/j.socscimed.2020.113364
   PubMed Web of Science ®Google Scholar
• Mamary AJ, Stewart JI, Kinney GL, et al. Race and gender disparities are evident in COPD underdiagnoses across all severities of measured airflow obstruction. Chronic Obstr Pulm Dis J COPD Found. 2018;5(3):177. doi:10.15326/JCOPDF.5.3.2017.0145
   PubMed Web of Science ®Google Scholar
• Ejike CO, Dransfield MT, Hansel NN, et al. Chronic obstructive pulmonary disease in America’s black population the black population. Am J Respir Crit Care Med. 2019;200(4):423–430. doi:10.1164/rccm.201810-1909PP
   PubMed Web of Science ®Google Scholar
• Gaffney AW, Hawks L, White AC, et al. Health care disparities across the urban-rural divide: a national study of individuals with COPD. J Rural Heal. 2022;38(1):207–216. doi:10.1111/JRH.12525
   PubMed Web of Science ®Google Scholar
• Gaffney AW, Hawks L, Bor D, et al. National trends and disparities in health care access and coverage among adults with asthma and COPD: 1997–2018. Chest. 2021;159(6):2173–2182. doi:10.1016/J.CHEST.2021.01.035
   PubMed Web of Science ®Google Scholar
• Han MLK, Curran-Everett D, Dransfield MT, et al. Racial differences in quality of life in patients with COPD. Chest. 2011;140(5):1169–1176. doi:10.1378/chest.10-2869
   PubMed Web of Science ®Google Scholar
• Arnett MJ, Thorpe RJ, Gaskin DJ, Bowie JV, LaVeist TA. Race, medical mistrust, and segregation in primary care as usual source of care: findings from the exploring health disparities in integrated communities study. J Urban Heal. 2016;93(3):456–467. doi:10.1007/S11524-016-0054-9/TABLES/2
   PubMed Web of Science ®Google Scholar
• Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance—United States, 1999–2011. Chest. 2013;144(1):284–305. doi:10.1378/CHEST.13-0809
   PubMed Web of Science ®Google Scholar
• Bruse S, Sood A, Petersen H, et al. New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med. 2011;184(11):1254–1260. doi:10.1164/rccm.201103-0568OC
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ. A review of the Hispanic paradox: time to spill the beans? Eur Respir Rev. 2014;23(134):439–449. doi:10.1183/09059180.00000814
   PubMedGoogle Scholar
• Nastars DR, Rojas JD, Ottenbacher KJ, Graham JE. Race/ethnicity and 30-day readmission rates in medicare beneficiaries with COPD. Respir Care. 2019;64(8):931–936. doi:10.4187/respcare.06475
   PubMed Web of Science ®Google Scholar
• Powell R, Davidson D, Divers J, et al. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study. Thorax. 2013;68(7):634–642. doi:10.1136/THORAXJNL-2012-202116/-/DC1
   PubMed Web of Science ®Google Scholar
• Thaweethai T, Jolley SE, Karlson EW, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934–1946. doi:10.1001/jama.2023.8823
   PubMed Web of Science ®Google Scholar
• Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626–631. doi:10.1038/s41591-021-01292-y
   PubMed Web of Science ®Google Scholar
• Crook H, Raza S, Nowell J, Young M, Edison P. Long covid—mechanisms, risk factors, and management. BMJ. 2021;374. doi:10.1136/BMJ.N1648
   Google Scholar
• Sisó-Almirall A, Brito-Zerón P, Ferrín LC, et al. Long covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health. 2021;18(8):4350. doi:10.3390/IJERPH18084350/S1
   PubMed Web of Science ®Google Scholar
• Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi:10.1136/BMJOPEN-2020-048391
   PubMed Web of Science ®Google Scholar
• Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res. 2011;11:11. doi:10.1186/1472-6963-11-43
   PubMed Web of Science ®Google Scholar
• Stanford RH, Nag A, Mapel DW, et al. Validation of a new risk measure for chronic obstructive pulmonary disease exacerbation using health insurance claims data. Ann Am Thorac Soc. 2016;13(7):1067–1075. doi:10.1513/AnnalsATS.201508-493OC
   PubMed Web of Science ®Google Scholar
• Make B, Dutro MP, Paulose-Ram R, Marton JP, Mapel DW. Undertreatment of COPD: a retrospective analysis of us managed care and medicare patients. Int J COPD. 2012;7:1–9. doi:10.2147/COPD.S27032
   Google Scholar